___________________________________________________________________
Prediction Market Edge
April 23, 2026
Have you ever seen a $20 bill, on weed?
If you can guess correctly what movie that’s from we’ll feature your favorite charity here or something.
Fox News, among many others reported announced the United States is set to reclassify marijuana as early as Wednesday.
Cannabis stocks moved. Social media lit up.
The prediction market were blazing on whether Satan's Spinach gets rescheduled before 2027 is sitting at exactly 50% on Kalshi…
And on Polymarket it’s a little different… this is as of Thursday evening.
So what gives? If the Trump administration is shifting medical marijuana from SCHEDULE I to SCHEDULE III…
Why aren’t all the odds 99%?
What Rescheduling Actually Means
Marijuana has been classified as a Schedule I controlled substance since 1970 — the most restrictive category, reserved for drugs with "no accepted medical use" and high abuse potential. Same category as heroin.
The rescheduling process is now Trump's decision. The formal DEA rulemaking framework exists, the proposed rule is on the table, and the question is whether Trump's DOJ and DEA finish the job. Trump has personally signaled openness to rescheduling. But some conservatives within his administration are actively opposed, and the process hasn't visibly accelerated since he took office. The regulatory machinery moves at the speed of political will — and right now, that will is the variable the market is trying to price.
The proposal is to move jazz cabbage to Schedule III.
A significant downgrade that would acknowledge accepted medical use and lower abuse potential. It would not legalize the wacky tobaccy federally. It would not expunge criminal records.
But it would have massive practical implications for the cannabis industry, banking access, research, and the broader federal framework around the drug.
Why The Market Isn't At 90%
This is why you read the rules and the resolution criteria.
Read the Polymarket clarification carefully: the mere announcement or publication of a Final Rule in the Federal Register does NOT satisfy the resolution criteria if the rule has not taken legal effect.
The market resolves based on the actual legal status of marijuana under the Controlled Substances Act.
Which could take days, weeks, months…
Federal rulemaking has multiple steps: proposed rule, public comment period, final rule publication, implementation date.
A Reuters headline saying rescheduling is happening "as early as Wednesday" could mean a final rule is being published — not that marijuana has legally moved schedules yet.
Sorry!
The Three Markets Tell Three Stories
Kalshi is running three contracts on different timelines and the spread between them is informative:
Before 2027: 50%. Before 2028: 78%.
Before January 20, 2029 (end of Trump's term): 86%.
This means the crowd thinks rescheduling almost certainly happens during Trump's second term.
Probably happens before the end of 2027, but is genuinely uncertain about whether it clears the legal finish line before January 1, 2027.
Still, there’s $6+ million in volume across those three contracts is a lot of money behind the devils lettuce.
The Cannabis Industry Stakes
This isn't just a political story, or a pothead story.
Rescheduling from Schedule I to Schedule III would have concrete industry implications.
Cannabis companies currently can't deduct standard business expenses on federal taxes under a provision called 280E — which only applies to Schedule I and II substances.
Moving to Schedule III eliminates that restriction, dramatically improving the economics of every cannabis business operating legally at the state level.
Banking access, research funding, federal employee drug testing policies — all of these shift meaningfully with a schedule change.
Can you imagine going to your local Walgreens and picking up an eighth?
What Could Move The Market
A final rule published in the Federal Register with an implementation date before December 31, 2026 would push the Kalshi Before 2027 contract dramatically higher. Obviously, but still, think about what could keep it at or below 50%
legal challenges from opponents of rescheduling
conservative groups have already signaled they'll sue
administrative delays
maybe the Trump administration decides to revisit the entire process instead of pushing this one through.
Could be anything.
The Honest Read
50/50 on Before 2027 feels about right given the current information environment. The direction is clear, rescheduling is coming eventually, but man there’s a lot of time between now and expiration and who knows how slow or fast things will move in DC.
The uncertainty is all too real. The Polymarket June 30 contract at 12% is the market saying: even if Reuters is right about "as early as Wednesday," the legal process doesn't move that fast. Be careful out there, and look out for when they officially reschedule the devils lettuce!
Sponsored:
Following big money is the (second) biggest edge in prediction markets.
The first? Prediction Market Whale CONSENSUS.
Brand new inside the prediction market whales platform...
Check it out today, absolutely free. Three days to try it out.
No credit card required.
___________________________________________________________________
DISCLAIMER:
The Content is not intended to provide, and does not constitute, financial, investment, trading, tax, legal, or any other form of professional advice. It is not a recommendation, suggestion, solicitation, or offer to buy, sell, trade, or hold any securities, event contracts, derivatives, cryptocurrencies, or other financial instruments on platforms such as Polymarket, Kalshi, or any other prediction market.
Prediction Market Edge believes the Content is reliable but makes no representations or warranties as to its accuracy, completeness, timeliness, or suitability for any purpose. The Content is subject to change without notice, and Prediction Market Edge assumes no duty or obligation to update it.
Trading in prediction markets involves significant risk of loss, including the potential loss of your entire investment. Past performance (including any highlighted “wins” or gains) is not indicative of future results. Markets are volatile, influenced by news, liquidity, resolution rules, and other factors, and individual results will vary. Subscribers and readers should conduct their own independent research, consider their financial situation, risk tolerance, and objectives, and consult qualified professionals before making any trading or investment decisions.
Prediction Market Edge is not responsible for any third-party information, market data, platform rules, or services referenced herein, including but not limited to Polymarket, Kalshi, or other exchanges. Use of the Content is at your own risk.
By subscribing to or accessing this Newsletter or related materials, you agree that Prediction Market Edge and its affiliates shall not be liable for any direct, indirect, incidental, consequential, or other damages arising from your use of the Content.
For important additional information, please review our full Terms of Service, Privacy Policy, and any Subscription Agreement (available on predictionmarketedge.com).